AWARDDELIVERY ORDEROther than small business
Delivery order SPE2DP26F1088MERIDIAN MEDICAL TECHNOLOGIES, LLC
Overview
Award facts
- Net obligations
- $16.41M
- $16,411,500of $16.41M potential value
- Period of performance
- Dec 8, 2025 to Sep 9, 2026
- Ended
- Modifications
- 1
- Latest action Dec 9, 2025
- Contract type
- Delivery order
- PIID SPE2DP26F1088
Description of requirement
8511797933!ANTIDOTE TREATMENT
Dates and value
- Award date
- Signed on Dec 8, 2025
- Potential end of performance
- Sep 8, 2026
- Current value
- $16,411,500Base and exercised options
- Potential value (if all options are exercised)
- $16,411,500
- Parent contract vehicle
- SPE2DP26D0001 (IDC, single award) — 3 orders recorded under it
Obligations by fiscal year of action
- FY2026: $16,411,500
Total across 1 fiscal year: $16,411,500
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Jul 31, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 9, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationSAINT LOUIS, MO
UEIVBM4PLZ9VBC4
CAGE code54452
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyMERIDIAN MEDICAL TECHNOLOGIES LLC
Business types and certifications
For-profit organizationLimited liability companyCorporation (not tax-exempt)Manufacturer of goods
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Defense Logistics Agency
- DLA TROOP SUPPORT
- Funded by
- Department of Defense
- Defense Logistics Agency
- DLA TROOP SUPPORT
Place of performance
- Place of performance
- Saint Louis, Missouri 63146-4105
- Congressional district (place of performance)
- MO-01As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not available for competitionB
- Reason not competed
- Only one source-other (FAR 6.302-1 other)ONE
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- Not reported
- Contract pricing
- Firm fixed priceJ
Contract details
- Subcontracting plan
- Commercial subcontract planG
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Transaction history
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Department of Defense9700
- IT commercial item category
- Not IT products or servicesZ
- Awarding agency code
- 9700
- Awarding sub-tier code
- 97AS
- Contracting office code
- SPE2DP
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 97AS
- Funding office code
- SPE2DP